1.47

3.92% -0.06

After Hours: 1.55 0.08 +5.44%

Rani Therapeutics Holdings Inc (RANI)

Overview News Price History Option Chain Financials Discussions Forecast

Rani Therapeutics Holdings Inc stock is traded at $1.47, with a volume of 462.13K. It is down -3.92% in the last 24 hours and up +8.09% over the past month. Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Previous Close:

$1.53

Open:

$1.54

24h Volume:

462.13K

Relative Volume:

0.49

Market Cap:

$48.97M

Revenue:

$3.04M

Net Income/Loss:

$-33.97M

P/E Ratio:

-1.1053

EPS:

-1.33

Net Cash Flow:

$-52.47M

1W Performance:

-3.29%

1M Performance:

+8.09%

6M Performance:

-50.34%

1Y Performance:

-60.16%

1-Day Range:

$1.4101

$1.54

1-Week Range:

$1.4101

$1.58

52-Week Range:

$1.24

$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name

Rani Therapeutics Holdings Inc

Sector

Healthcare (1170)

Industry

Biotechnology (682)

Phone

(408) 457-3700

Address

2051 RINGWOOD AVENUE, SAN JOSE

Employee

140

Twitter

Next Earnings Date

2024-11-08

Latest SEC Filings

RANI's Discussions on Twitter

Compare RANI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RANI Rani Therapeutics Holdings Inc	1.47	48.97M	3.04M	-33.97M	-52.47M	-1.33
VRTX Vertex Pharmaceuticals Inc	483.31	124.11B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	74.87B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.83B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.53B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	26.75B	3.30B	-501.07M	1.03B	-2.1146

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-02-24	Initiated	Oppenheimer	Outperform
Jun-14-24	Initiated	Maxim Group	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Apr-17-23	Resumed	BTIG Research	Buy
Oct-11-22	Initiated	UBS	Buy
Jul-27-22	Initiated	H.C. Wainwright	Buy
Jun-13-22	Initiated	Wedbush	Outperform

View All

Rani Therapeutics Holdings Inc Stock (RANI) Latest News

Mar 01, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Mar 01, 2025

Feb 27, 2025

Canaccord Genuity Group Reiterates Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Feb 27, 2025

Feb 15, 2025

Power to the People: How Individual Investors Shape Rani Therapeutics - Smartphone Magazine

Feb 15, 2025

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week - Yahoo Finance

Feb 15, 2025

Feb 14, 2025

RANI Shares Experience Surge in Value - Knox Daily

Feb 14, 2025

Janney Montgomery Scott LLC Buys New Position in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World

Feb 14, 2025

Feb 12, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Feb 12, 2025

Feb 11, 2025

Rani Therapeutics (NASDAQ:RANI) Given Buy Rating at HC Wainwright - MarketBeat

Feb 11, 2025

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Feb 11, 2025

Feb 10, 2025

Analyzing PSQ Holdings Inc (PSQH) After Recent Trading Activity - Knox Daily

Feb 10, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at HC Wainwright - Defense World

Feb 10, 2025

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable

Feb 10, 2025

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Shares Up 0.7%Time to Buy? - MarketBeat

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Receives “Buy” Rating from HC Wainwright - Armenian Reporter

Feb 08, 2025

Feb 07, 2025

Was there any good news for Rani Therapeutics Holdings Inc (RANI) stock in the last session? - US Post News

Feb 07, 2025

Is Rani Therapeutics Holdings (NASDAQ:RANI) Using Too Much Debt? - Simply Wall St

Feb 07, 2025

Feb 06, 2025

Market cap of Tantech Holdings Ltd [TANH] reaches 1.11M – now what? - The DBT News

Feb 06, 2025